Kalshi prediction market platform is drawing fresh investor interest at valuations of $10 billion to $12 billion, weeks after its $300 million funding round at a $5 billion valuation. Kalshi prediction market operator is attracting fresh investor interest at valuations…Kalshi prediction market platform is drawing fresh investor interest at valuations of $10 billion to $12 billion, weeks after its $300 million funding round at a $5 billion valuation. Kalshi prediction market operator is attracting fresh investor interest at valuations…

Kalshi prediction market platform draws VC interest at $10-12B valuations

2025/10/23 16:46
2 min read
For feedback or concerns regarding this content, please contact us at crypto.news@mexc.com

Kalshi prediction market platform is drawing fresh investor interest at valuations of $10 billion to $12 billion, weeks after its $300 million funding round at a $5 billion valuation.

Summary
  • Venture capitalists are discussing investments that could more than double Kalshi’s valuation.
  • Recent interest follows rapid growth after Kalshi’s 2024 court victory enabling presidential election contracts.

Kalshi prediction market operator is attracting fresh investor interest at valuations exceeding $10 billion, people familiar with the discussions told Bloomberg.

The offers come just weeks after the New York–based company closed a $300 million round at a $5 billion valuation, led by Andreessen Horowitz and Sequoia Capital. Earlier this year, Kalshi had raised $185 million at a $2 billion valuation in a deal backed by Paradigm.

The new funding momentum builds on Kalshi’s rapid ascent following a pivotal 2024 court victory that cleared the way for trading on U.S. presidential election contracts, driving activity to record highs. Kalshi has since expanded its licensed markets to include sports outcomes, fueling competition with rival Polymarket, which recently secured backing from Intercontinental Exchange at an $8 billion valuation.

Prediction markets under regulatory pressure

Despite the growing investor enthusiasm around prediction markets, regulatory scrutiny remains a significant hurdle for Kalshi and the sector. While the Commodity Futures Trading Commission has granted Kalshi the authority to list certain event-based contracts, state-level gaming regulators have pushed back, particularly around sports betting, arguing that some markets may fall under traditional gambling laws.

For instance, the Massachusetts Attorney General recently filed a lawsuit accusing Kalshi of operating an unlicensed sports wagering platform, highlighting concerns over public health risks and consumer protections.

Experts also caution that prediction markets could be vulnerable to market manipulation and insider trading, especially in contracts tied to sensitive political or corporate events. For example, traders with advance knowledge of election results, policy announcements, or corporate disclosures could potentially exploit these platforms for profit, raising legal and ethical concerns.

Kalshi has implemented compliance measures and monitoring systems to detect suspicious trading activity, but long-term regulatory clarity remains uncertain.

Market Opportunity
VinuChain Logo
VinuChain Price(VC)
$0.0003
$0.0003$0.0003
-1.96%
USD
VinuChain (VC) Live Price Chart
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact crypto.news@mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.

You May Also Like

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves

The post Health Insurers To Cover Covid Vaccines Despite RFK, Jr. Moves appeared on BitcoinEthereumNews.com. The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee, America’s Health Insurance Plans said Wednesday, Sept. 17, 2025. In this photo is a free flu and Covid-19 vaccine shots available sign, CVS, Queens, New York. (Photo by: Lindsey Nicholson/Universal Images Group via Getty Images) UCG/Universal Images Group via Getty Images The nation’s biggest health insurance companies will continue to cover vaccinations – including those against Covid-19 and seasonal flu – previously recommended by a federal advisory committee. The announcement by America’s Health Insurance Plans (AHIP), which includes CVS Health’s Aetna, Humana, Cigna, Centene and an array of Blue Cross and Blue Shield plans as members, comes ahead of the first meeting of the reconstituted Advisory Committee on Immunization Practices, which now has new members chosen by U.S. Health and Human Services Secretary Robert F. Kennedy Jr., a vaccine critic. “Health plans are committed to maintaining and ensuring affordable access to vaccines,” AHIP said in a statement Wednesday. “Health plan coverage decisions for immunizations are grounded in each plan’s ongoing, rigorous review of scientific and clinical evidence, and continual evaluation of multiple sources of data.” The move by AHIP is good news for millions of Americans at a time of year when they flock to drugstores, pharmacies, physician’s offices and outpatient clinics to get their seasonal flu and Covid shots. Kennedy’s changes to U.S. vaccine policy have created confusion across the country over whether certain vaccines long covered by insurance would continue to be. AHIP has now provided some clarity for millions of Americans. “Health plans will continue to cover all ACIP-recommended immunizations that were recommended as of September 1, 2025, including updated formulations of the COVID-19 and influenza vaccines, with no cost-sharing…
Share
BitcoinEthereumNews2025/09/18 03:11
Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift

The post Standard Chartered’s Critical March Forecast Signals Monetary Policy Shift appeared on BitcoinEthereumNews.com. RBA Rate Hike: Standard Chartered’s Critical
Share
BitcoinEthereumNews2026/03/12 16:05
X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain Partners with Symbiosis to Pioneer Cross-Chain Interoperability Ahead of Mainnet Launch

X1 EcoChain and Symbiosis are joining forces, making it possible to move assets seamlessly across 45-plus chains with mainnet launch right around the corner.
Share
Blockchainreporter2026/03/12 16:00